Effect of dietary intake of fat-soluble vitamins on intensity of experimental swine influenza virus infection in mice

Virology ◽  
1956 ◽  
Vol 2 (3) ◽  
pp. 415-429 ◽  
Author(s):  
Norman R. Underdahl ◽  
George A. Young
2019 ◽  
Vol 71 (3) ◽  
pp. 622-629 ◽  
Author(s):  
Laura K Borkenhagen ◽  
Guo-Lin Wang ◽  
Ryan A Simmons ◽  
Zhen-Qiang Bi ◽  
Bing Lu ◽  
...  

Abstract Background China is thought to be a hotspot for zoonotic influenza virus emergence, yet there have been few prospective studies examining the occupational risks of such infections. Methods We present the first 2 years of data collected from a 5-year, prospective, cohort study of swine-exposed and -unexposed participants at 6 swine farms in China. We conducted serological and virological surveillance to examine evidence for swine influenza A virus infection in humans. Results Of the 658 participants (521 swine-exposed and 137 swine-unexposed), 207 (31.5%) seroconverted against at least 1 swine influenza virus subtype (swine H1N1 or H3N2). Swine-exposed participants’ microneutralization titers, especially those enrolled at confined animal feeding operations (CAFOs), were higher against the swine H1N1 virus than were other participants at 12 and 24 months. Despite elevated titers, among the 187 study subjects for whom we had complete follow-up, participants working at swine CAFOs had significantly greater odds of seroconverting against both the swine H1N1 (odds ratio [OR] 19.16, 95% confidence interval [CI] 3.55–358.65) and swine H3N2 (OR 2.97, 95% CI 1.16–8.01) viruses, compared to unexposed and non-CAFO swine workers with less intense swine exposure. Conclusions While some of the observed increased risk against swine viruses may have been explained by exposure to human influenza strains, study data suggest that even with elevated preexisting antibodies, swine-exposed workers were at high risk of infection with enzootic swine influenza A viruses.


2010 ◽  
Vol 88 (1) ◽  
pp. 172-178 ◽  
Author(s):  
Filip Barbé ◽  
Xavier Saelens ◽  
Debby Braeckmans ◽  
François Lefèvre ◽  
Kristien Van Reeth

2011 ◽  
Vol 204 (8) ◽  
pp. 1165-1171 ◽  
Author(s):  
Fatimah S. Dawood ◽  
Libo Dong ◽  
Feng Liu ◽  
Dianna M. Blau ◽  
Patrick J. Peebles ◽  
...  

2006 ◽  
Vol 112 (3-4) ◽  
pp. 117-128 ◽  
Author(s):  
Pravina Kitikoon ◽  
Dachrit Nilubol ◽  
Barbara J. Erickson ◽  
Bruce H. Janke ◽  
Thayer C. Hoover ◽  
...  

2009 ◽  
Vol 83 (19) ◽  
pp. 10198-10210 ◽  
Author(s):  
Aleksandar Masic ◽  
Jayaum S. Booth ◽  
George K. Mutwiri ◽  
Lorne A. Babiuk ◽  
Yan Zhou

ABSTRACT Influenza A viruses cause significant morbidity in swine, resulting in a substantial economic burden. Swine influenza virus (SIV) infection also poses important human public health concerns. Vaccination is the primary method for the prevention of influenza virus infection. Previously, we generated two elastase-dependent mutant SIVs derived from A/Sw/Saskatchewan/18789/02(H1N1): A/Sw/Sk-R345V (R345V) and A/Sw/Sk-R345A (R345A). These two viruses are highly attenuated in pigs, making them good candidates for a live-virus vaccine. In this study, the immunogenicity and the ability of these candidates to protect against SIV infection were evaluated in pigs. We report that intratracheally administrated R345V and R345A induced antigen-specific humoral and cell-mediated immunity characterized by increased production of immunoglobulin G (IgG) and IgA antibodies in the serum and in bronchoalveolar lavage fluid, high hemagglutination inhibition titers in serum, an enhanced level of lymphocyte proliferation, and higher numbers of gamma interferon-secreting cells at the site of infection. Based on the immunogenicity results, the R345V virus was further tested in a protection trial in which pigs were vaccinated twice with R345V and then challenged with homologous A/Sw/Saskatchewan/18789/02, H1N1 antigenic variant A/Sw/Indiana/1726/88 or heterologous subtypic H3N2 A/Sw/Texas/4199-2/9/98. Our data showed that two vaccinations with R345V provided pigs with complete protection from homologous H1N1 SIV infection and partial protection from heterologous subtypic H3N2 SIV infection. This protection was characterized by significantly reduced macroscopic and microscopic lung lesions, lower virus titers from the respiratory tract, and lower levels of proinflammatory cytokines. Thus, elastase-dependent SIV mutants can be used as live-virus vaccines against swine influenza in pigs.


2002 ◽  
Vol 8 (8) ◽  
pp. 814-819 ◽  
Author(s):  
Christopher W. Olsen ◽  
Lynnette Brammer ◽  
Bernard C. Easterday ◽  
Nancy Arden ◽  
Ermias Belay ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document